Attia, S., Kolesar, J., Mahoney, M. R., Pitot, H. C., Laheru, D., Heun, J., . . . Holen, K. D. (2008). A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas. Invest New Drugs.
Citação norma ChicagoAttia, Steven, et al. "A Phase 2 Consortium (P2C) Trial of 3-aminopyridine-2-carboxaldehyde Thiosemicarbazone (3-AP) for Advanced Adenocarcinoma of the Pancreas." Invest New Drugs 2008.
Deismireacht MLAAttia, Steven, et al. "A Phase 2 Consortium (P2C) Trial of 3-aminopyridine-2-carboxaldehyde Thiosemicarbazone (3-AP) for Advanced Adenocarcinoma of the Pancreas." Invest New Drugs 2008.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.